(Q46664509)

English

Phase I trial and pharmacokinetics of escalating doses of paclitaxel and concurrent hyperfractionated radiotherapy with or without amifostine in patients with advanced head and neck carcinoma

scientific article published in October 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116597

Phase I trial and pharmacokinetics of escalating doses of paclitaxel and concurrent hyperfractionated radiotherapy with or without amifostine in patients with advanced head and neck carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116597

phase I clinical trial

0 references

adaptive radiation therapy

0 references

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Philip C Amrein

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116597

John R Clark

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116597

Jeffrey G Supko

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116597

Richard L Fabian

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116597

Chiu C Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116597

A Dimitrios Colevas

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116597

Marshall R Posner

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116597

Daniel G Deschler

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116597

James W Rocco

9

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116597

Dianne M Finkelstein

10

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116597

James F McIntyre

11

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116597

language of work or name

0 references

publication date

1 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116597

number of pages

10

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116597

104

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116597

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116597

1418-1427

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116597

Pharmacokinetics of WR-1065 in mouse tissue following treatment with WR-2721

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

21 January 2018

Head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

Current chemotherapy of head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the Head and Neck Contracts Program

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

Organ-function preservation in advanced oropharynx cancer: results with induction chemotherapy and radiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

Twice-a-day radiation therapy for cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

Accelerated hyperfractionation radiation therapy for carcinoma of the nasopharynx. Techniques and results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolution of the Radiation Therapy Oncology Group clinical trials for head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

A Phase I/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel: an active drug for squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

Taxol: an antimitotic agent with a new mechanism of action

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

Radioprotective effect of amifostine in patients with head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

Alkaline phosphatase promotes radioprotection and accumulation of WR-1065 in V79-171 cells incubated in medium containing WR-2721

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

WR-1065 and radioprotection of vascular endothelial cells. I. Cell proliferation, DNA synthesis and damage

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of liposomal doxorubicin and weekly paclitaxel for recurrent Müllerian tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

Adaptation of solid phase extraction to an automated column switching method for online sample cleanup as the basis of a facile and sensitive high-performance liquid chromatographic assay for paclitaxel in human plasma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: five-year results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase II study of high-dose paclitaxel with or without amifostine in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacologic study of paclitaxel administered with or without the cytoprotective agent amifostine, and given as a single agent or in combination with epirubicin and cisplatin in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21312

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.21312

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116597

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16116597

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46664509&oldid=2144633792"